Mitchell Clark

8PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsInnate immunityPredictive and prognostic markersFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 14, 2026
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.

|Apr 16, 2024
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.

Stefania Bellone, Kyungjo Jeong, Mari Kyllesø Halle

|Apr 09, 2024
Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).

Sangini S Sheth, Ji Eun Oh, Stefania Bellone

|Sep 07, 2023
In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma.

Levent Mutlu, Diego D Manavella, Stefania Bellone

|Aug 28, 2023
Delayed presentation of placenta accreta following a first-trimester medical abortion.

Jenna Maurer, Sangeeta Ramani, Bo Xu

|Nov 17, 2021
A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin.

Mitchell Clark, Alexandra Kollara, Theodore J Brown

Pageof 2

Frequent Collaborators

6 joint publications

Alessandro D Santin

6 joint publications

Vaagn Andikyan

5 joint publications

Peter E Schwartz

5 joint publications

Gloria S Huang